Results 11 to 20 of about 41,059 (214)
Determinants of Hyperkalemia Progression Among Patients with Mild Hyperkalemia [PDF]
The progression of mild hyperkalemia and the predictors of progression have not been well characterized. In this study we aimed to characterize the progression of hyperkalemia and identify the risk factors for hyperkalemia progression.Adults with mild hyperkalemia (at least one serum potassium measure > 5.0 and ≤ 5.5 mEq/L) were identified using ...
Rubeen Israni+9 more
openaire +3 more sources
Recurrent Hyperkalemia During General Anesthesia in a Dog
Objective: To describe the development of recurrent hyperkalemia in a dog that underwent general anesthesia at two different hospitals within a month. The definitive underlying cause of the hyperkalemia remains unknown.Case summary: A 11 year-old male ...
Carissa W. Tong+2 more
doaj +1 more source
Daptomycin‐induced hyperkalemia: A case report and brief description of mechanism
Key Clinical Message Daptomycin causes serious side effects like rhabdomyolysis at high doses. At lower doses it can cause isolated hyperkalemia without frank rhabdomyolysis.
Praveen Errabelli+2 more
doaj +1 more source
CAQ Corner: Basic concepts of transplant immunology
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley +1 more source
Background Patients with end-stage renal disease (ESRD) especially those undergoing dialysis have a high prevalence of hyperkalemia, which must be detected and treated immediately.
Daojun Xu+12 more
doaj +1 more source
Management of hyperkalemia in the acutely ill patient. [PDF]
PURPOSE:To review the mechanisms of action, expected efficacy and side effects of strategies to control hyperkalemia in acutely ill patients. METHODS:We searched MEDLINE and EMBASE for relevant papers published in English between Jan 1, 1938, and July 1,
Dépret, François+5 more
core +3 more sources
Pseudohypoaldosteronism type 1 due to novel variants of SCNN1B gene. [PDF]
UnlabelledAutosomal recessive pseudohypoaldosteronism type 1 (PHA1) is a rare disorder characterized by sodium wasting, failure to thrive, hyperkalemia, hypovolemia and metabolic acidosis.
Abraham, Smita B+9 more
core +2 more sources
BackgroundData on the true burden of hyperkalemia in patients with heart failure (HF) in a real‐world setting are limited. Methods and ResultsIncidence rates of hyperkalemia (first blood test with a potassium level >5.0 mmol/L) in primary or hospital ...
Reimar Wernich Thomsen+8 more
doaj +1 more source
Serum potassium levels and outcome in acute heart failure (data from the PROTECT and COACH trials) [PDF]
Serum potassium is routinely measured at admission for acute heart failure (AHF), but information on association with clinical variables and prognosis is limited.
Bloomfield, Daniel M.+18 more
core +3 more sources